Inventor · disambiguated record
Matthew G. Donahue
Also filed as: DONAHUE MATTHEW · DONAHUE MATTHEW G · DONAHUE MATTHEW GARRETT
17 granted patents·3 pending applications·85 citations·filing 2013–2020
91Inventor score
Top patents by PatentIndex Score
20 records- 0195US9410972B2Antibodies to quetiapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Aug 9, 2016·17 cites·20 claims
- 0294US9494608B2Antibodies to olanzapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Nov 15, 2016·15 cites·25 claims
- 0392US9850318B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 26, 2017·16 cites·15 claims
- 0491US9303041B2Haptens of olanzapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·29 claims
- 0591US9304126B2Haptens of quetiapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·21 claims
- 0679US9611259B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 4, 2017·3 cites·13 claims
- 0771US11046786B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 29, 2021·0 cites·20 claims
- 0870US2021017294A9Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0969US11214566B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 4, 2022·0 cites·12 claims
- 1069US2019271712A1Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1164US10712353B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jul 14, 2020·0 cites·7 claims
- 1263US11104742B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·21 claims
- 1362US11226345B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 18, 2022·0 cites·15 claims
- 1462US10800764B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Oct 13, 2020·0 cites·10 claims
- 1560US10071991B2Substituted pyridine derivatives useful as c-fms kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·0 cites·3 claims
- 1659US10465013B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 5, 2019·0 cites·14 claims
- 1759US10288631B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 14, 2019·0 cites·12 claims
- 1858US10344098B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 9, 2019·0 cites·25 claims
- 1957US10435478B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 8, 2019·0 cites·25 claims
- 2056US2014057303A1Antibodies to Olanzapine Haptens and Use ThereofJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →